8 Stories in coverage 0 Programs 0 Registered trials 8-K Sep 30 Latest SEC filing Sep 30 Latest story
Timeline 8 Pipeline 0 Trials 0
All8 Trials and readouts2 Filings and people6
Details
Headquarters San Diego, CA Incorporated Delaware Industry Biological Products, (No Diagnostic Substances) Formerly HALOZYME THERAPEUTICS INC (to 2019); GLOBAL YACHT SERVICES INC (to 2004) Also known as GLOBAL YACHT SERVICES INC, HALO, HALOZYME THERAPEUTICS, INC. How the company describes itself Halozyme develops ENHANZE®, a subcutaneous drug delivery technology using the enzyme rHuPH20, licensed to pharmaceutical companies for ten commercialized products across over 100 markets. The company also develops Hypercon™, a microparticle hyperconcentration technology to reduce injection volume. source
